See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618835_2023_Evofem_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001618835, Evofem Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,699,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,940,000 |
| 3 | remainder_Assets | 8,524,000 |
| 4 | LiabilitiesCurrent | 93,830,000 |
| 5 | LiabilitiesNoncurrent | 3,133,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,415,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,563,000 |
| 9 | ResearchAndDevelopmentExpense | 25,032,000 |
| 10 | remainder_Expenses | 43,995,000 |
| 11 | remainder_Revenues | 16,837,000 |
| 12 | remainder_NetIncome | 7,470,000 |
| 13 | remainder_ComprehensiveNetIncome | 44,438,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,163,000 |
| 1 | Liabilities | 96,963,000 |
| 2 | Expenses | 101,005,000 |
| 3 | Revenues | 16,837,000 |
| 4 | StockholdersEquity | -71,800,000 |
| 5 | NetIncome | -76,698,000 |
| 6 | ComprehensiveNetIncome | -54,479,000 |
| 7 | BaseVar | 145,938,000 |
| 8 | EconomicCapitalRatio | -2.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
